Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-018388

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Mar 15, 2018
Accepted (ET)
Mar 16, 2018 · 6:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Mar 15, 2018A8,969$0.00A57,066D
Common StockF3holding———99,668ISee footnote
Common StockF4holding———5,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$19.79Mar 15, 2018A20,827A—Mar 15, 2028Common Stock20,82720,827D

Explanation of responses